Skip to main navigation
Acadia
  • Home
  • Contact
  • Home
  • About
    • Management Team
    • Board Of Directors
    • Our Purpose, Mission & Values
    • History
  • Product
  • Pipeline
    • Dementia-Related Psychosis
    • Rett syndrome
    • Schizophrenia – Negative Symptoms
    • Early Stage Clinical Programs
  • Resources
    • Parkinson’s Disease Psychosis
    • Clinical Trials
    • Investigator Initiated Trials
    • Medical Education Grants
    • Scientific Publications
  • Partnering
  • Investors
    • Stock Information
    • News Releases
    • Events & Presentations
    • Sec Filings
    • Corporate Governance
    • Financial Information
    • Analyst Coverage
    • Annual Report and Proxy
    • Information Request
    • Email Alerts
  • Media
  • Careers
  • Contact
  • About
    • Management Team
    • Board Of Directors
    • Our Purpose, Mission & Values
    • History
  • Product
  • Pipeline
    • Dementia-Related Psychosis
    • Rett Syndrome
    • Schizophrenia – Negative Symptoms
    • Early Stage Clinical Programs
  • Resources
    • Parkinson’s Disease Psychosis
    • Clinical Trials
    • Investigator Initiated Trials
    • Medical Education Grants
    • Scientific Publications
  • Partnering
  • Investors
    • Stock Information
    • News Releases
    • Events & Presentations
    • SEC Filings
    • Corporate Governance
    • Financial Information
    • Analyst Coverage
    • Annual Report and Proxy
    • Information Request
    • Email Alerts
  • Media
  • Careers
banner

Corporate Governance Documents

Audit Committee 212 KB
Compensation Committee 211.9 KB
Nominating and Corporate Governance Committee 252.5 KB
Code of Business Conduct and Related Open Door Policy 603.3 KB
Annual Declaration of Compliance for California 182 KB

Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Chairperson Member Financial Expert
Chairman of the Board
  Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Stephen Biggar, M.D., Ph.D.     Compensation Committee   Nominating and Corporate Governance Committee
Julian C. Baker     Compensation Committee  
Laura A. Brege   Audit Committee     Nominating and Corporate Governance Committee
Jim Daly   Audit Committee   Compensation Committee  
Stephen R. Davis      
Edmund P. Harrigan, M.D.      
Daniel B. Soland   Audit Committee     Nominating and Corporate Governance Committee
 

Investor Relations

  • INVESTORS
  • STOCK INFORMATION
  • NEWS RELEASES
  • EVENTS & PRESENTATIONS
  • SEC FILINGS
  • CORPORATE GOVERNANCE
  • FINANCIAL INFORMATION
  • ANALYST COVERAGE
  • ANNUAL REPORT AND PROXY
  • INFORMATION REQUEST
  • EMAIL ALERTS
  • Investor Contact

Shareholder Tools

  • Print Page
  • RSS Feeds
  • Share
  • Privacy
  • Cookies
  • Privacy
    Shield
  • Terms
  • Email

© 2021 Acadia Pharmaceuticals Inc. Acadia and NUPLAZID are registered
trademarks of Acadia Pharmaceuticals Inc. All rights reserved.

This website uses cookies to improve and customize your experience on our website. By using this website without changing your cookie settings in your browser, you agree to our use of cookies. For further details on cookies, how we use cookies and how to delete or block the use of cookies, please read our Cookie Policy.

ACCEPT